Ae Wealth Management LLC Repligen Corp Transaction History

Ae Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$161.19 - $257.96 $127,017 - $203,272	-788 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$247.59 - $304.47 $9,408 - $11,569	38 Added 5.07%	788 $209,000
Q3 2021 Nov 01, 2021	BUY	$194.77 - $324.21 $146,077 - $243,157	750 New	750 $217,000
Q2 2021 Jul 21, 2021	SELL	$165.87 - $220.95 $828,686 - $1.1 Million	-4,996 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$180.37 - $226.26 $184,698 - $231,690	1,024 Added 25.78%	4,996 $971,000
Q4 2020 Feb 01, 2021	SELL	$148.08 - $206.57 $110,615 - $154,307	-747 Reduced 15.83%	3,972 $761,000
Q3 2020 Nov 06, 2020	BUY	$122.51 - $158.27 $578,124 - $746,876	4,719 New	4,719 $696,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.